Clinical trial
A Phase II, Multi-center, Open-label, Randomized Study of Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
NCT01501370 is registered in ClinicalTrials.gov with Tiziana Marangon as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II, Multi-center, Open-label, Randomized Study of Vorinostat Plus Lenalidomide and Dexamethasone or Lenalidomide Plus Dexamethasone in Multiple Myeloma Patients Who Experience Biochemical Relapse During Lenalidomide Maintenance Therapy
- Lead sponsor
- Tiziana Marangon
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- January 31, 2012
- Completion date
- January 31, 2012
- Enrollment
- 0 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.